Development and implementation of delivery and quality control system for cellular therapies: experience in 500 patients.
Miesowicz
F
F
Cellcor Inc., Newton, MA 02159.
du Moulin
G
G
Liu
V
V
Hamilton
D
D
Davies
B
B
Pitkin
Z
Z
Stack
J
J
Chew-Darke
J
J
Osband
M
M
D001804:Blood Transfusion, Autologous / Q000592:standards; D002292:Carcinoma, Renal Cell / Q000276:immunology / Q000628:therapy*; D006801:Humans; D016130:Immunophenotyping; D016219:Immunotherapy, Adoptive; D007680:Kidney Neoplasms / Q000276:immunology / Q000628:therapy*; D008213:Lymphocyte Activation; D017710:Lymphocyte Transfusion / Q000592:standards; D011786:Quality Control; D013601:T-Lymphocytes / Q000276:immunology*; D014481:United States